Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China. The company offers fully automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products. It also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis system; automated chemiluminescence immunoassay system; and blood analyzer. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Corporation in September 2020. Thalys Medical Technology Group Corporation was founded in 2004 and is headquartered in Wuhan, China.
Research context
Thalys Medical Technology Group Inc appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Diagnostics & Research
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Thalys Medical Technology Group Inc is currently in a long term downtrend where the price is trading 9.6% below its 200 day moving average.
From a valuation standpoint, the stock is 85.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.
Thalys Medical Technology Group Inc's total revenue rose by 25.0% to $585M since the same quarter in the previous year.
Its net income has dropped by 35.5% to $21M since the same quarter in the previous year.
Finally, its free cash flow fell by 2593.1% to $-102M since the same quarter in the previous year.
Based on the above factors, Thalys Medical Technology Group Inc gets an overall score of 2/5.